Thursday 1 November
A key element of the AusBiotech 2018 conference is a one-day Early Stage Investment Forum featuring 20 presentations
to an expert investor panel from local research institutes, universities and hospitals in sectors including drug discovery,
biopharmaceuticals and human therapeutics.
The investor panel will include international big pharma representatives as well as corporate VCs and early stage investors
Institutes are invited to submit their interest to be considered for a presentation on the program. Submissions received will be evaluated and reviewed by the appointed Advisory Group and applicants will be contacted with further information.
Conditions and requirements:
· Successful applicants will present on Thursday 1 November between 11.00am – 5.00pm at the AusBiotech 2018 conference in Brisbane;
· Submissions are only open to research based projects from Australian institutions;
· Institutes will be allocated 7 minutes per presentation, with a further 5 minutes for Q&A from the experienced investor panel;
· Upon acceptance, a template will be provided with a limit of 5 slides per presentation
Deadline: submissions must be received by no later than 31 August 2018